- €34.89bn
- €37.81bn
- €22.52bn
- 96
- 34
- 90
- 88
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 14,125 | 15,848 | 18,160 | 21,995 | 22,522 |
Cost of Revenue | |||||
Gross Profit | 3,851 | 4,136 | 4,792 | 5,832 | 6,048 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 12,692 | 14,346 | 16,321 | 19,602 | 20,176 |
Operating Profit | 1,433 | 1,502 | 1,839 | 2,393 | 2,346 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1,354 | 1,355 | 1,680 | 2,264 | 2,304 |
Provision for Income Taxes | |||||
Net Income After Taxes | 852 | 955 | 1,154 | 1,554 | 1,678 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 856 | 957 | 1,157 | 1,547 | 1,664 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 856 | 957 | 1,157 | 1,547 | 1,663 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 5.49 | 6.59 | 7.53 | 9.44 | 10.4 |
Dividends per Share |